Heterologous Immune Responses of Serum IgG and Secretory IgA Against the Spike Protein of Endemic Coronaviruses During Severe COVID-19

Defining immune correlates of disease severity is important to better understand the immunopathogenesis in COVID-19. Here we made use of a protein microarray platform to detect IgG- and IgA-reactive antibodies in sera and saliva respectively, and assess cross-reactivity between SARS-CoV-2 and endemi...

Full description

Bibliographic Details
Main Authors: Wouter L. Smit, Sophie van Tol, Sanne van der Wal, Femke van Vulpen, Shannon la Grouw, Lenneke van Lelyveld, Gijs Limonard, Ailko Bossink, Gert-Jan Godeke, Sandhya Shrestha, Johan Reimerink, Dirk Eggink, Chantal Reusken, Michiel Heron, Steven Thijsen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.839367/full
_version_ 1819122326024749056
author Wouter L. Smit
Wouter L. Smit
Sophie van Tol
Sanne van der Wal
Femke van Vulpen
Shannon la Grouw
Lenneke van Lelyveld
Gijs Limonard
Ailko Bossink
Gert-Jan Godeke
Sandhya Shrestha
Johan Reimerink
Dirk Eggink
Chantal Reusken
Michiel Heron
Steven Thijsen
author_facet Wouter L. Smit
Wouter L. Smit
Sophie van Tol
Sanne van der Wal
Femke van Vulpen
Shannon la Grouw
Lenneke van Lelyveld
Gijs Limonard
Ailko Bossink
Gert-Jan Godeke
Sandhya Shrestha
Johan Reimerink
Dirk Eggink
Chantal Reusken
Michiel Heron
Steven Thijsen
author_sort Wouter L. Smit
collection DOAJ
description Defining immune correlates of disease severity is important to better understand the immunopathogenesis in COVID-19. Here we made use of a protein microarray platform to detect IgG- and IgA-reactive antibodies in sera and saliva respectively, and assess cross-reactivity between SARS-CoV-2 and endemic coronaviruses (eCoVs). IgG responses against the full protein of spike, but not the S1 subunit, were significantly higher in convalescent sera of patients with severe disease compared to mild disease and healthy controls. In addition, we detected reactivity of secretory IgA to eCoVs in saliva of patients with severe disease, not present in patients with moderate disease or seropositive healthy controls. These heterologous immune responses are in line with non-protective cross-reactivity, and support a potential role for immune imprinting in the pathogenesis of severe COVID-19.
first_indexed 2024-12-22T06:50:40Z
format Article
id doaj.art-56c6023616cd4ffdb9c836ce5a805f9e
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-22T06:50:40Z
publishDate 2022-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-56c6023616cd4ffdb9c836ce5a805f9e2022-12-21T18:35:09ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-03-011310.3389/fimmu.2022.839367839367Heterologous Immune Responses of Serum IgG and Secretory IgA Against the Spike Protein of Endemic Coronaviruses During Severe COVID-19Wouter L. Smit0Wouter L. Smit1Sophie van Tol2Sanne van der Wal3Femke van Vulpen4Shannon la Grouw5Lenneke van Lelyveld6Gijs Limonard7Ailko Bossink8Gert-Jan Godeke9Sandhya Shrestha10Johan Reimerink11Dirk Eggink12Chantal Reusken13Michiel Heron14Steven Thijsen15Department of Medical Microbiology and Immunology, Diakonessenhuis Utrecht, Utrecht, NetherlandsDepartment of Medical Microbiology, University Medical Center Utrecht, Utrecht, NetherlandsCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, NetherlandsDepartment of Medical Microbiology and Immunology, Diakonessenhuis Utrecht, Utrecht, NetherlandsDepartment of Medical Microbiology and Immunology, Diakonessenhuis Utrecht, Utrecht, NetherlandsDepartment of Medical Microbiology and Immunology, Diakonessenhuis Utrecht, Utrecht, NetherlandsDepartment of Intensive Care, Diakonessenhuis Utrecht, Utrecht, NetherlandsDepartment of Pulmonary Diseases, Diakonessenhuis Utrecht, Utrecht, NetherlandsDepartment of Pulmonary Diseases, Diakonessenhuis Utrecht, Utrecht, NetherlandsCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, NetherlandsCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, NetherlandsCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, NetherlandsCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, NetherlandsCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, NetherlandsDepartment of Medical Microbiology and Immunology, Diakonessenhuis Utrecht, Utrecht, NetherlandsDepartment of Medical Microbiology and Immunology, Diakonessenhuis Utrecht, Utrecht, NetherlandsDefining immune correlates of disease severity is important to better understand the immunopathogenesis in COVID-19. Here we made use of a protein microarray platform to detect IgG- and IgA-reactive antibodies in sera and saliva respectively, and assess cross-reactivity between SARS-CoV-2 and endemic coronaviruses (eCoVs). IgG responses against the full protein of spike, but not the S1 subunit, were significantly higher in convalescent sera of patients with severe disease compared to mild disease and healthy controls. In addition, we detected reactivity of secretory IgA to eCoVs in saliva of patients with severe disease, not present in patients with moderate disease or seropositive healthy controls. These heterologous immune responses are in line with non-protective cross-reactivity, and support a potential role for immune imprinting in the pathogenesis of severe COVID-19.https://www.frontiersin.org/articles/10.3389/fimmu.2022.839367/fullSARS-CoV-2COVID-19spike proteinseasonal coronavirusesimmune imprinting
spellingShingle Wouter L. Smit
Wouter L. Smit
Sophie van Tol
Sanne van der Wal
Femke van Vulpen
Shannon la Grouw
Lenneke van Lelyveld
Gijs Limonard
Ailko Bossink
Gert-Jan Godeke
Sandhya Shrestha
Johan Reimerink
Dirk Eggink
Chantal Reusken
Michiel Heron
Steven Thijsen
Heterologous Immune Responses of Serum IgG and Secretory IgA Against the Spike Protein of Endemic Coronaviruses During Severe COVID-19
Frontiers in Immunology
SARS-CoV-2
COVID-19
spike protein
seasonal coronaviruses
immune imprinting
title Heterologous Immune Responses of Serum IgG and Secretory IgA Against the Spike Protein of Endemic Coronaviruses During Severe COVID-19
title_full Heterologous Immune Responses of Serum IgG and Secretory IgA Against the Spike Protein of Endemic Coronaviruses During Severe COVID-19
title_fullStr Heterologous Immune Responses of Serum IgG and Secretory IgA Against the Spike Protein of Endemic Coronaviruses During Severe COVID-19
title_full_unstemmed Heterologous Immune Responses of Serum IgG and Secretory IgA Against the Spike Protein of Endemic Coronaviruses During Severe COVID-19
title_short Heterologous Immune Responses of Serum IgG and Secretory IgA Against the Spike Protein of Endemic Coronaviruses During Severe COVID-19
title_sort heterologous immune responses of serum igg and secretory iga against the spike protein of endemic coronaviruses during severe covid 19
topic SARS-CoV-2
COVID-19
spike protein
seasonal coronaviruses
immune imprinting
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.839367/full
work_keys_str_mv AT wouterlsmit heterologousimmuneresponsesofserumiggandsecretoryigaagainstthespikeproteinofendemiccoronavirusesduringseverecovid19
AT wouterlsmit heterologousimmuneresponsesofserumiggandsecretoryigaagainstthespikeproteinofendemiccoronavirusesduringseverecovid19
AT sophievantol heterologousimmuneresponsesofserumiggandsecretoryigaagainstthespikeproteinofendemiccoronavirusesduringseverecovid19
AT sannevanderwal heterologousimmuneresponsesofserumiggandsecretoryigaagainstthespikeproteinofendemiccoronavirusesduringseverecovid19
AT femkevanvulpen heterologousimmuneresponsesofserumiggandsecretoryigaagainstthespikeproteinofendemiccoronavirusesduringseverecovid19
AT shannonlagrouw heterologousimmuneresponsesofserumiggandsecretoryigaagainstthespikeproteinofendemiccoronavirusesduringseverecovid19
AT lennekevanlelyveld heterologousimmuneresponsesofserumiggandsecretoryigaagainstthespikeproteinofendemiccoronavirusesduringseverecovid19
AT gijslimonard heterologousimmuneresponsesofserumiggandsecretoryigaagainstthespikeproteinofendemiccoronavirusesduringseverecovid19
AT ailkobossink heterologousimmuneresponsesofserumiggandsecretoryigaagainstthespikeproteinofendemiccoronavirusesduringseverecovid19
AT gertjangodeke heterologousimmuneresponsesofserumiggandsecretoryigaagainstthespikeproteinofendemiccoronavirusesduringseverecovid19
AT sandhyashrestha heterologousimmuneresponsesofserumiggandsecretoryigaagainstthespikeproteinofendemiccoronavirusesduringseverecovid19
AT johanreimerink heterologousimmuneresponsesofserumiggandsecretoryigaagainstthespikeproteinofendemiccoronavirusesduringseverecovid19
AT dirkeggink heterologousimmuneresponsesofserumiggandsecretoryigaagainstthespikeproteinofendemiccoronavirusesduringseverecovid19
AT chantalreusken heterologousimmuneresponsesofserumiggandsecretoryigaagainstthespikeproteinofendemiccoronavirusesduringseverecovid19
AT michielheron heterologousimmuneresponsesofserumiggandsecretoryigaagainstthespikeproteinofendemiccoronavirusesduringseverecovid19
AT steventhijsen heterologousimmuneresponsesofserumiggandsecretoryigaagainstthespikeproteinofendemiccoronavirusesduringseverecovid19